Navigation Links
Pharmacogenomics in Medical News

New Study Shows That Pharmacogenomics Could Benefit Patients, Spur Investment in Innovation

WASHINGTON, Aug. 3 /PRNewswire-USNewswire/ -- A new study funded by the National Pharmaceutical Council (NPC) shows that pharmacogenomics -- the field of scientific research focused on learning how genetic profiles predict the body's response to medicines - has the potential to lead to h...

GeneGo Awarded NIH Grant to Develop Pharmacogenomics Software Suite

ST. JOSEPH, Mich., July 28 /PRNewswire/ -- GeneGo, Inc., the leading systems biology company, today announced that it has been awarded a grant to develop an integrated systems pharmacology platform for pharmacogenomic research. The SBIR grant, funded through the innovations in ...

Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?

In this weeks press release: Could anemia be used to assess the burden and control of neglected tropical diseases" Translating pharmacogenomics: challenges on the road to the clinic Please mention PLoS Medicine in your report and use the links below to take your readers straight to...

UC San Diego to lead nationwide program in pharmacogenomics

The Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego, will collaborate with the American Pharmacists Association, the American Society of Health-System Pharmacists, and the American Association of Colleges of Pharmacy to promote PharmGenEd, in an edu...

Medco, LabCorp Strike Strategic Agreement for Research on Personalized Medicine and Pharmacogenomics

Collaboration to Explore Clinical Uses of Personal Genetics and Tamoxifen FRANKLIN LAKES, NJ and BURLINGTON, NC, Oct. 22 /PRNewswire-FirstCall/ -- Medco Health Solutions Inc. (NYSE: MHS ) and Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH ) announced a strategic research...

Special One-Day Rates Available For DIA 45th Annual Meeting June 21-25 in San Diego

...Landscape Current event sessions Hot topics! Phase 1 Early Development, Accelerated Development Time, US FDA Sentinel Initiative, Transparency, pharmacogenomics and Personalized Medicines and much more! Pharma in the New Age of Transparency Meet the Regulators CDER Town Meeting Parts 1 and 2 Europ...

'Ambry Genetics Announces Launch of Chromosomal Microarray to Offer Whole Genome Analysis'

...ort within the industry. Since the company's inception in 2000, it has become a leader in providing genetic services focused on clinical diagnostics, pharmacogenomics and research support. Ambry has built a solid reputation for unparalleled service, and has been at the forefront of applying new technologies to the c...

Ambry Genetics Announces Illumina CSPro Certification for GA Sequencing

... Aliso Viejo, California. Since the company's inception in 2000, it has become a leader in providing genetic services focused on clinical diagnostics, pharmacogenomics and research support. Ambry has built a solid reputation for unparalleled service, and has been at the forefront of applying new technologies. To lear...

Aurora Health Care Unveils ORBIT, A Cutting-Edge Research Instrument

...he development of personalized medicine, says Randall Lambrecht, Ph.D., Aurora's vice president of research and academic relations. "The field of pharmacogenomics aims to find a way to determine the most effective drug for an individual with the fewest side effects, based on that person's genetic makeup," Lambre...

Medco Tops Fortune's Lists of 'World's Most Admired' Companies

... patient health and lowering overall medical costs. This is accomplished by partnering with member advocacy programs to engage and educate consumers, pharmacogenomics research that helps physicians in the selection of the right medicine and dose based on a patient's unique genetic make-up as well as other clinical i...
Pharmacogenomics in Medical Technology

National Cancer Institute Research Identifies Unique Mechanism of Brostallicin's Anti-Tumor Effectiveness

...Systems Medicine, a privately-held oncology company, in a stock-for-stock merger. SM applies a systems biology approach to drug development, combining pharmacogenomics and bioinformatics with experienced preclinical, clinical, and regulatory expertise to find and exploit a specific cancer's 'context of vulnerability....

Genes Identified That Enhance Tumor Cell Sensitivity to CTI's Cancer Drug Brostallicin

...cal development and drug combination studies by incorporating an integrated pharmacogenomics approach. The study was conducted by SM in collaboration with the Translati...erger. SM applies a systems biology approach to drug development, combining pharmacogenomics and bioinformatics with experienced preclinical, clinical, and regulatory e...

Transgenomic and Power3 Medical Complete Agreement for Exclusive License of Neurodegenerative Biomarker Test

...ratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Specific offerings inc..., Cytogenetics automated systems, and Transgenomic pharmacogenomics and Reference Laboratory Services. Transgenomic pharmacogenomics and Laboratory Services utilize their technology a...

Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma

...ms Medicine (SM), a privately held oncology company, in a stock-for-stock merger. SM applies a systems biology approach to drug development, combining pharmacogenomics and bioinformatics with experienced preclinical, clinical and regulatory expertise to find and exploit a specific cancer's 'context of vulnerability.'...

Transgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines

...ratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Specific offerings incl..., Cytogenetics automated systems, and Transgenomic pharmacogenomics and Reference Laboratory Services. Transgenomic pharmacogenomics and Laboratory Services utilize their technology a...

Preclinical Study Shows CTI's Brostallicin's Cancer-Killing Ability Based on Genetic Profiling

...ms Medicine (SM), a privately held oncology company, in a stock-for-stock merger. SM applies a systems biology approach to drug development, combining pharmacogenomics and bioinformatics with experienced preclinical, clinical, and regulatory expertise to find and exploit a specific cancer's 'context of vulnerability....

New Gene Discovery Suggests Which Patients CTI's Brostallicin May Benefit

...ms Medicine (SM), a privately-held oncology company, in a stock-for-stock merger. SM applies a systems biology approach to drug development, combining pharmacogenomics and bioinformatics with experienced preclinical, clinical, and regulatory expertise to find and exploit a specific cancer's 'context of vulnerability....

Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies

...ive Officer. "We are focused on generating continued strong momentum in our pharmacogenomics business and will continue fueling this growth through the recent addition ...l research, clinical laboratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Specific offerings include WAVE(R) DHPLC Systems...

Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial

... http://www.pharmatech.com . About Systems Medicine LLC Systems Medicine, LLC (SML), develops oncology products by integrating predictive cellular pharmacogenomics ("genomics") with world-class clinical and regulatory expertise. This allows SML to develop patient-selective therapies by defining the context of vul...

Genetic Variation Associated with Treatment Response in a Clinical Study of a New Atypical Antipsychotic Fiaptatm (iloperidone)

... ROCKVILLE, Md., Feb. 29 /PRNewswire-FirstCall/ -- A study reported in the journal pharmacogenomics suggests that a genetic variation in the Ciliary Neurotrophic Factor gene (CNTF) may affect response to antipsychotic treatment. The study, conducted ...
Pharmacogenomics in Medical Definition

Medicine

...lems related to work and the working environment. Osteopathic medicine claims that much disease results from problems with bones and joints. pharmacogenomics is a form of individualized medicine . PanVascular Medicine is an approach to deal with the problems of highly specialised but both, medical ...

Personalized medicine

...e W, Dai Z. (2005), Pharmacogenetics/genomics and personalized medicine, Hum Mol Genet. 2005 Oct 15;14 Spec No. 2:R207-14. Steven H. Y. Wong (2006), pharmacogenomics and Proteomics: Enabling the Practice of Personalized Medicine, American Association for Clinical Chemistry, ISBN 1-59425-046-4 External l...
Pharmacogenomics in Biological News

Launching a global alliance for pharmacogenomics

Leaders at the National Institutes of Health and the Center for Genomic Medicine in Japan have signed a letter of intent creating a Global Alliance for Pharmacogenomics. The effort aims to identify genetic factors that contribute to individual responses to medicines, including rare and dangerous s...

At Boston symposium, NARSAD researchers report on genes and family traits

...s may cause suicidal thinking and behavior in children, adolescents and adults ages 18 to 24. According to Roy Perlis, M.D., M.Sc., the director of pharmacogenomics research at Massachusetts General Hospital's Department of Psychiatry, specific genes may influence how individual patients respond to antidepressant ...

Many African-Americans have a gene that prolongs life after heart failure

...ents," says senior author Gerald W. Dorn II, M.D., professor of medicine, associate chairman for translational research and director of the Center for pharmacogenomics at Washington University. "By mimicking the effect of beta blockers, the genetic variant makes it appear as if beta blockers aren't effective in t...

Genetic variant mimics effect of heart failure medications

... patients, says co-author Gerald W. Dorn II, M.D., professor of medicine, associate chairman for translational research and director of the Center for pharmacogenomics at Washington University. By mimicking the effect of beta-blockers, the genetic variant makes it appear as if beta blockers arent effective in these...

AIBS to cohost symposium on evolution, disease and human health

...s, as well as policies around the use of racial taxonomies by publicly funded cell repositories. Her current project, Race and Distributive Justice in pharmacogenomics Research, includes the development of an anthropology of racial justice, with a particular focus on health disparities among populations. Davi...

UNC study questions FDA genetic-screening guidelines for cancer drug

...ven that low doses of the drug werent causing problems, said Howard McLeod, Pharm.D., senior author of the study and director of the UNC Institute for pharmacogenomics and Individualized Therapy. Our review showed that at low doses the drug is well tolerated and can be taken by most people, McLeod said. As the dos...

Large-scale genomics project will hunt genes behind common childhood diseases

...e company's important genome-wide mapping and association studies over the past several years, and served as director of Respiratory, Inflammatory and pharmacogenomics Research, vice president of Clinical Sciences, and later as vice president of Business Development. "Our goals for the Center are to generate new d...

St. Jude projects 90 percent cure rate for ALL

...ent," Evans said. "That's why the breakthroughs in pharmacogenomics made at St. Jude and elsewhere are so important. T...ng a lot of guesswork instead of good science." pharmacogenomics is the study of the effects of different genes on ...t in diagnosis and treatment made possible by MRD, pharmacogenomics and new drug therapies has shifted the focus in AL...

Mammalian Transcriptome Mapped

... works. "This is arguably the next major step after the human genome project," says Professor Claes Wahlestedt, M.D., Ph.D., who is the director of pharmacogenomics at Scripps Florida. Wahlestedt is also a professor at the Karolinska Institute in Sweden, and is adjunct chief scientist at RIKEN Institutes, Japan. "...

NIH renews network focused on how genes influence drug responses

...totals for each award. The Pharmacogenetics and pharmacogenomics Knowledge Base ( PharmGKB )--$13.7 million provide...ncisco) Consortium on Breast Cancer pharmacogenomics --$11.6 million provided by NIGMS, NIEHS, and ORWH... St. Jude Children's Research Hospital) pharmacogenomics of Arrhythmia Therapy --$14 million provided by NH...
Pharmacogenomics in Biological Technology

Transgenomic Opens Pharmacogenomics Laboratory in China

Provides New Opportunity to Serve Pharmaceutical Partner Interest for Clinical Trials in China OMAHA, Neb., March 31 /PRNewswire-FirstCall/ -- Transgenomic, Inc. (OTC Bulletin Board: TBIO), a global genetic analysis and services company, today announced that it has ente...

Response Genetics' CEO to Discuss Advances in Optimizing Therapy through Pharmacogenomics as Part of a Series of Presentations at AACR-NCI-EORTC International Conference

- Presentation to be Webcast as Part of AACR Virtual Meeting - LOS ANGELES, Oct. 19 /PRNewswire-FirstCall/ -- Response Genetics, Inc. (Nasdaq: RGDX ) today announced that Kathleen Danenberg, the Company's President and Chief Executive Officer, will give a presentation on the role of phar...

Webcast Alert: Transgenomic Inc. Announces Second Quarter 2009 Earnings Release Conference Call Webcast

...l research, clinical laboratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Specific offerings include WAVE((R)) DHPLC Syste...automated systems, Transgenomic Molecular Clinical Reference Laboratory and pharmacogenomics Research Services. Transgenomic's two laboratory services divisions utilize...

Transgenomic, Inc. Announces Appointment of New Board Members

...ratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Specific offerings incl..., Cytogenetics automated systems, and Transgenomic pharmacogenomics and Reference Laboratory Services. Transgenomic pharmacogenomics and Laboratory Services utilize their technology a...

Transgenomic, Inc. Reports First Quarter 2009 Results

...l research, clinical laboratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Specific offerings include WAVE(R) DHPLC Systems...automated systems, Transgenomic Molecular Clinical Reference Laboratory and pharmacogenomics Research Services. Transgenomic's two laboratory services divisions utilize...

Reminder: Transgenomic Inc. Announces First Quarter 2009 Earnings Release Conference Call Webcast

...l research, clinical laboratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Specific offerings include WAVE(R) DHPLC Systems...automated systems, Transgenomic Molecular Clinical Reference Laboratory and pharmacogenomics Research Services. Transgenomic's two laboratory services divisions utilize...

Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimer's and Parkinson's Diseases at AAN Annual Meeting

...ratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Specific offerings incl..., Cytogenetics automated systems, and Transgenomic pharmacogenomics and Reference Laboratory Services. Transgenomic pharmacogenomics and Laboratory Services utilize their technology a...

Webcast Alert: Transgenomic Inc. Announces First Quarter 2009 Earnings Release Conference Call Webcast

...l research, clinical laboratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Specific offerings include WAVE(R) DHPLC Systems...automated systems, Transgenomic Molecular Clinical Reference Laboratory and pharmacogenomics Research Services. Transgenomic's two laboratory services divisions utilize...

Ambry Genetics Announces the Addition of Array CGH Services Through Partnership With Baylor College of Medicine

...Aliso Viejo, California. Since the company's inception in 2000, it has become a leader in providing genetic services focused on clinical diagnostics, pharmacogenomics and research support. Ambry has built a solid reputation for unparalleled service, and has been at the forefront of applying new technologies to the c...

Transgenomic Completes Licensing Option With Dana-Farber Cancer Institute on Cold-PCR for Enrichment of DNA Mutations

...ratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Specific offerings incl..., Cytogenetics automated systems, and Transgenomic pharmacogenomics and Reference Laboratory Services. Transgenomic pharmacogenomics and Laboratory Services utilize their technology a...
Pharmacogenomics in Biological Products

Functional Genomics & Pharmacogenomics from Dominion Pharmakine S.L.

Description: Gene expression profiling allows a high-throuput screening of a biological systems phenotype, so that naturally occuring or artifitially induced changes in the expression levels of the genes in that system can be detected, studied, classified and compared to each other, covering a broad range of ge...
Company:Dominion Pharmakine S.L.
Pharmacogenomics in Biological Definition

Promoter

... diseases respond differently to treatment as a result of differences in the underlying molecular origins is partially addressed by the discipline of pharmacogenomics . Asthma population genetics study: Hobbs, K.; Negri, J.; Klinnert, M.; Rosenwasser, L.J.; and Borish, L. (1998). Interleukin-10 and tra...
Pharmacogenomics in Biological Dictionary

Polymorphisms

... suite of products in the ... Polymorphisms ... Single Nucleotide Polymorphisms - SNPs - SNP genotyping information and resources available for pharmacogenomics - Building on the Human Genome Project Methylenetetrahydrofolate reductase (MTHFR) is 'a critical enzyme in both folate and homocysteine metaboli...

Membrane transporter

... Transporter Glossary. Relevant Databases and Web Sources. Transporter pharmacogenomics ... Membrane Transporter pharmacogenomics ... The apical membrane contains the sodium-glucose cotransporter SGLU...
Other Tags
(Date:12/26/2014)... The Biofeedback Federation of Europe annual meeting is ... Italy and is hosted by the Salesian Pontifical University. ... wide variety of topics such as ADHD, anxiety, headaches ... athletes. The scientific program will feature the latest in ... clients to see what is going on in their ...
(Date:12/26/2014)... Seattle, WA (PRWEB) December 26, 2014 ... to deal with personal injury claim issues and phone ... their recently released an article featuring their free ... The exceptionally helpful eBook on pedestrian and bicycle auto ... injury attorney is fully capable of professionally handling their ...
(Date:12/26/2014)... 26, 2014 Pentec Health, Inc. number ... state of Pennsylvania for 2014. The awards program, created ... of its kind in the country. The program is ... Department of Community and Economic Development, the Pennsylvania State ... the Central Penn Business Journal. , Charlie ...
(Date:12/26/2014)... December 26, 2014 Parker & ... the best in heating, cooling and plumbing contractor ... hour emergency services in 2014 with regard to ... that Arizona is known for its incredibly hot ... understands the intricacies and details of a wide ...
(Date:12/25/2014)... TX (PRWEB) December 26, 2014 This ... state of the global Sterilizers industry with a focus ... on the market status of the Sterilizers manufacturers and ... companies and individuals interested in the industry. This report ... definition, applications and manufacturing technology. In this part, the ...
Breaking Medicine News(10 mins):Health News:Final Workshop Line-up Announced for 18th Annual Biofeedback Conference in Rome, Italy 2Health News:Guide to Handling Pedestrian and Bicycle Accidents Released By The Jones Firm, Featured in Recent Article 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 3Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3
(Date:12/22/2014)... Dec. 22, 2014  The 2014 Holiday Season ... industry as Acuity Market Intelligence reports that the ... be open. Acuity forecasts that intensifying demand for ... incorporate biometrics will drive a global market of ... devices by 2020.   According to ...
(Date:12/19/2014)... Dec. 18, 2014 Research and Markets ... "Micro Market Monitor: North America Perimeter Security Systems ... http://photos.prnewswire.com/prnh/20130307/600769 The North American ... CAGR of 3.6% from 2014 to 2019. Although the ... Canada is expected to grow ...
(Date:12/19/2014)... 18, 2014   LaunchKey , the first decentralized ... and Internet of Things era, today announced the close ... round was led by Metamorphic Ventures with participation from ... VegasTechFund, and others.  LaunchKey has raised $4 million to ... its team and bring LaunchKey to market in 2015. ...
Breaking Biology News(10 mins):First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3
Other Contents